Paper8094293
Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.
Jensen PB and 4 others. Br J Cancer, 1993. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines. Papers, record 8094293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8094293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Carcinoma, Small Cell | Major topic |
| Etoposide | Major topic |
| Lung Neoplasms | Major topic |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| DNA Topoisomerases, Type II | |
| Daunorubicin | |
| Drug Resistance | |
| Drug Screening Assays, Antitumor | |
| Humans | |
| Membrane Glycoproteins | |
| Tumor Cells, Cultured |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2574988 | In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL). | Br J Cancer | 1989 | https://conductscience.org/library/papers/2574988 | PubMed |
| 2 | 2557299 | Reduced variation in the clonogenic assay obtained by standardization of the cell culture conditions prior to drug testing on human small cell lung cancer cell lines. | Invest New Drugs | 1989 | https://conductscience.org/library/papers/2557299 | PubMed |
| 3 | 1347865 | Management of small-cell cancer of the lung. | Lancet | 1992 | https://conductscience.org/library/papers/1347865 | PubMed |
| 4 | 1314232 | In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data. | Int J Cancer | 1992 | https://conductscience.org/library/papers/1314232 | PubMed |
| 5 | 1581902 | Relationship of VP-16 to the classical multidrug resistance phenotype. | Cancer Res | 1992 | https://conductscience.org/library/papers/1581902 | PubMed |
| 6 | 1350507 | Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. | Cancer Res | 1992 | https://conductscience.org/library/papers/1350507 | PubMed |
| 7 | 1318157 | The 1991 Merck Frosst Award. Multidrug resistance in small cell lung cancer. | Can J Physiol Pharmacol | 1992 | https://conductscience.org/library/papers/1318157 | PubMed |
| 8 | 1360876 | Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity. | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1360876 | PubMed |
| 9 | 1967222 | Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line. | Cancer Res | 1990 | https://conductscience.org/library/papers/1967222 | PubMed |
| 10 | 2359137 | Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. | J Natl Cancer Inst | 1990 | https://conductscience.org/library/papers/2359137 | PubMed |
| 11 | 1976450 | Characterization of an etoposide-resistant human small-cell lung cancer cell line. | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/1976450 | PubMed |
| 12 | 2174738 | Elevated expression of DNA topoisomerase II in camptothecin-resistant human tumor cell lines. | Cancer Res | 1990 | https://conductscience.org/library/papers/2174738 | PubMed |
| 13 | 2272241 | A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. | Cytometry | 1990 | https://conductscience.org/library/papers/2272241 | PubMed |
| 14 | 1846554 | Chemosensitivity testing of small cell lung cancer using the MTT assay. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1846554 | PubMed |
| 15 | 1963547 | Correlation of in vitro drug sensitivity testing of long-term small cell lung cancer cell lines with response and survival. | Eur J Cancer | 1990 | https://conductscience.org/library/papers/1963547 | PubMed |
| 16 | 1672252 | Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1672252 | PubMed |
| 17 | 2023272 | MDR1 gene expression and treatment outcome in acute myeloid leukemia. | J Natl Cancer Inst | 1991 | https://conductscience.org/library/papers/2023272 | PubMed |
| 18 | 1674875 | Multidrug resistance (mdr) genes in human cancer. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1674875 | PubMed |
| 19 | 1675932 | Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II. | Cancer Res | 1991 | https://conductscience.org/library/papers/1675932 | PubMed |
| 20 | 1874739 | Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. | J Biol Chem | 1991 | https://conductscience.org/library/papers/1874739 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31638975 | Investigation of anti-cancer and migrastatic properties of novel curcumin derivatives on breast and ovarian cancer cell lines. | BMC Complement Altern Med | 2019 | https://conductscience.org/library/papers/31638975 | PubMed |
| 28178691 | P-glycoprotein attenuates DNA repair activity in multidrug-resistant cells by acting through the Cbp-Csk-Src cascade. | Oncotarget | 2017 | https://conductscience.org/library/papers/28178691 | PubMed |
| 24758331 | Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance. | Chem Rev | 2014 | https://conductscience.org/library/papers/24758331 | PubMed |
| 21144000 | Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase. | BMC Cancer | 2010 | https://conductscience.org/library/papers/21144000 | PubMed |
| 17047657 | TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis. | Br J Cancer | 2006 | https://conductscience.org/library/papers/17047657 | PubMed |
| 9062409 | In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9062409 | PubMed |
| 7765327 | Human cell lines as models for multidrug resistance in solid tumours. | Cytotechnology | 1993 | https://conductscience.org/library/papers/7765327 | PubMed |
| 7669558 | An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7669558 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| TOP2A | 7153 | PubTator's text mining | https://conductscience.org/library/genes/7153 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8094293
GET https://conductscience.org/api/papers/v1/8094293/references?page=2